Several CBD manufacturers would not speak on the record for fear of inviting federal retaliation, but said they’ve recently had trouble selling their products to non-cannabis retail stores. In January, the Seattle Central Co-op pulled CBD products from its shelves in reaction to the DEA rule. Meanwhile, CBD remains available online and at many retail health stores across the nation.
In 2017, state Governor Scott Walker signed and passed the 2017 Wisconsin Act 100. This law is described as a “pilot program to study growth, cultivation, and marketing of industrial hemp.” It allows the cultivation of “only industrial hemp of the species Cannabis sativa, with THC concentration of Non-Detectable.” Republican Representative Jesse Kremer sponsored the bill. He tweeted, “signing the bill will make Wisconsin a national and global leader in hemp production.” Wisconsin is joining over 30 other states across the country that are taking advantage of this new cash crop.
In the United States, CBD itself is not specifically listed in the United States Controlled Substances Act like the psychoactive compound, tetrahydrocannabinol (THC). The US government, which specifies which parts of cannabis plants are prohibited, excludes hemp’s “mature stalks” and “oil or cake made from the seeds” and “sterilized seeds” from its definition of “marihuana.”